Open Beta
TREN
MetriLume
TREN

US marketsSNTI

SEC-sourced researchBeta

SNTI

Senti Biosciences Holdings, Inc.

Company comparison ↗

Data passport

CIK
0001854270
Exchange
Nasdaq
Business activity
— · SIC 2836
Financial inputs
6/6
Filing date
Sep 24, 2026
SEC registry record
Operating company
Last updated: SEC company ticker catalog ↗SEC Financial Statement Data Sets ↗SEC investment company series and class registry ↗

Annual financial history

Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table.

Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table. Exact amounts and source periods: December 2024: 0.0000 USD; December 2025: 22,000.0000 USD22K USD0 USD0December 2024December 2025
SNTI · Exact amounts and source periods · USD
Period endRevenueFiling date
December 20240.0000Mar 27, 2026
December 202522,000.0000Mar 27, 2026

Annual periods · USD

Period endRevenueNet incomeOperating cash flowTotal assetsTotal liabilitiesFiling date
December 202522,000.0000-61,438,000.0000-43,444,000.000051,223,000.000045,634,000.0000Mar 27, 2026
December 20240.0000-52,790,000.0000-41,397,000.000097,841,000.000047,086,000.0000Mar 27, 2026

Financial inputs behind the calculation

Financial inputsUSDPeriod endFiling dateForm
RevenueRevenueFromContractWithCustomerExcludingAssessedTax$22KDecember 2025Mar 27, 202610-K
Previous period revenueRevenueFromContractWithCustomerExcludingAssessedTax$0December 2024Mar 27, 202610-K
Net incomeNetIncomeLoss-$61.44MDecember 2025Mar 27, 202610-K
Operating cash flowNetCashProvidedByUsedInOperatingActivities-$43.44MDecember 2025Mar 27, 202610-K
Total assetsAssets$51.22MDecember 2025Mar 27, 202610-K
Total liabilitiesLiabilities$45.63MDecember 2025Mar 27, 202610-K

New filings

Explore methodology ↗